Top Markets
Coin of the day
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc.

ASBP
Classificação em ações #38702
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise... Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
Preço da ação
$7.37
Valor de mercado
$850.29K
Variação (1 dia)
3.66%
Variação (1 ano)
-98.43%
País
US
Negociar Aspire Biopharma Holdings, Inc. (ASBP)

Categoria

Histórico de desdobramentos de ações de Aspire Biopharma Holdings, Inc. (ASBP)
As ações Aspire Biopharma Holdings, Inc. (símbolo: ASBP) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 14, 2026.
Uma ação ASBP comprada antes de Aug 14, 2026 equivaleria hoje a 0 ações ASBP.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE